Jan 13, 2021 / 09:30PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team. Our next presenting company is Atara Bio. And speaking on behalf of the company, we have CEO, Pascal Touchon. (Operator Instructions). With that, I'll pass it over to you, Pascal.
Pascal Touchon - Atara Biotherapeutics, Inc. - President, CEO & Director
Thank you, Anupam, and thanks to JPMorgan for inviting us to this esteemed conference once again. We -- after the forward-looking statement, I would like us to move to Slide 3, where we explain why we're doing what we do at Atara Biotherapeutics. During what has been clearly across the world and for each and every of us, a very challenging year, our team at Atara has been working very hard to transform the life of patients with serious disease.
In 2021, we are committed to deliver further value to patients and to our
Atara Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers